• Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages

    المصدر: Buzz FX / 20 ديسمبر 2024 05:02:11   America/New_York


    Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has received a
    Read more...
شارك على،